At Pack Expo, Schreiner MediPharm Will Showcase New RFID Labels with Digital Seal Function

An innovative solution for secure, transparent automated medication management

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, will showcase its new RFID label with digital first-opening indication at Pack Expo 2024, November 3-6 in Chicago. The new solution – which irreversibly indicates a container’s initial opening, and enables automated integrity tracking – will be among those displayed at the company’s Booth W-16094.

Digitization and process automation are increasingly sought-after in healthcare settings, as such setups increase product safety and avoid medication errors. Labels with integrated RIFD chips can play an important role, since they are used for product marking while simultaneously enabling unique unit-dose digital IDs. This is a decisive prerequisite for complete end-to-end tracking of containers within the supply chain. However, in hectic hospital settings it must also be ensured that the integrity of prefilled syringes or vials has not been compromised prior to medication administration.

Schreiner MediPharm’s new RFID label comprises an integrated digital sealing function whose design irreversibly indicates a container’s initial opening, and enables automated integrity tracking. This eliminates the need to manually check whether the container has already been opened. This not only makes work easier for medical staff, but also optimizes inventory management, since unused medication can be efficiently returned to stock. At the same time, possible diversions and medication misuse can be monitored.

Schreiner MediPharm’s new label features a special design that reliably protects the integrated chip from mechanical stress and impact during the pharmaceutical production process; this buffering effect can pay particular dividends for manufacturers utilizing high-speed dispensing systems. The result is a digital seal that can be reliably read from production to final application – an important aspect in ensuring seamless unit-level medication tracking for increased product and patient safety.

Also at Pack Expo, Schreiner MediPharm will highlight recently introduced label solutions for applications with sensitive APIs, as well as its latest sustainability-minded product solutions. For example, the company’s Needle-Trap Secu combines needlestick safety elements with an integrated first-opening indication – a setup that eliminates the need for an additional blister pack, resulting in considerable space savings as well as reduced waste and cost.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”